R. Decristofaro et al., BINDING OF HUMAN ALPHA-THROMHIN TO PLATELET GPLB - ENERGETICS AND FUNCTIONAL-EFFECTS, Biochemical journal, 332, 1998, pp. 643-650
Thrombin interaction with platelet glycocalicin (GC), the 140 kDa extr
acytoplasmic fragment of the membrane glycoprotein Ib, was investigate
d by using a solid-phase assay. Thrombin bound to GC-coated polystyren
e wells was detected by measuring the hydrolysis of a chromogenic subs
trate. The monoclonal antibody LJ-Ib10, which specifically binds to th
e thrombin-binding site of GC, could displace thrombin from immobilize
d GC, whereas the monoclonal antibody LJ-Ib1, which interacts with the
von Willebrand factor-binding domain of GC, did not affect thrombin b
inding to GC. Competitive inhibition of thrombin binding to immobilize
d GC was also observed using GC in solution or ligands that bind to th
e thrombin heparin-binding site, such as heparin and prothrombin fragm
ent 2. Furthermore functional experiments demonstrated that GC binding
to thrombin competes with heparin for thrombin inactivation by the an
tithrombin III-heparin complex as well. Thrombin-GC interaction was al
so studied as a function of temperature over the range 4-37 degrees C.
A large negative heat capacity change (Delta C-p,), of -4.14+/-0.8 kJ
mol(-1).K-1, was demonstrated to dominate the thermodynamics of throm
bin-GC complex-formation. Finally it was demonstrated that GC binding
to thrombin can allosterically decrease the enzyme affinity for hirudi
n via a simultaneous decrease in association rate and increase in the
dissociation velocity of the enzyme-inhibitor adduct. Together these o
bservations indicate the GC binding to the heparin-binding domain of t
hrombin is largely driven by a hydrophobic effect and that such intera
ction can protect the enzyme from inhibition by the heparin-anti-throm
bin III complex.